Filip De Vos
Utrecht University(NL)University Medical Center Utrecht(NL)University Medical Center Utrecht(NL)Leidsche Rijn Julius Health Centers(NL)
Publications by Year
Research Areas
Glioma Diagnosis and Treatment, Radiopharmaceutical Chemistry and Applications, Medical Imaging Techniques and Applications, Brain Metastases and Treatment, Radiomics and Machine Learning in Medical Imaging
Most-Cited Works
- → Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial(2014)745 cited
- → Combined BRAF, EGFR, and MEK Inhibition in Patients with BRAF V600E-Mutant Colorectal Cancer(2018)574 cited
- → Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter(2022)468 cited
- → Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial(2023)268 cited
- → Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence(2014)255 cited
- → Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature(2000)